The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.
Their innovative services range from R&D, biomarker discovery, development and commercialization, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has grown organically over the past five decades now employing over 6,000 highly skilled personnel across 18 facilities including Europe, the US and Asia.
Clinical Services
Almac has over 30 years’ experience delivering a full range of innovative clinical trial supply and technology solutions to pharmaceutical and biotech companies worldwide. They pride themselves on working with all types of companies, from virtual and biotech, to multi-national pharmaceutical companies. Almac currently provides services to over 600 pharmaceutical and biotech companies worldwide including 18 of the top 20 global pharma companies.
Headquartered in Craigavon, Northern Ireland - with US operations based in North Carolina and Pennsylvania, and Asia Pacific operations based in Singapore - Almac champions integrated clinical supply and technological excellence to make clinical trials more effective and efficient.
Almac is uniquely positioned and equipped to offer the most comprehensive, end-to-end, clinical supply chain solutions in the industry.
Global Clinical Trial Solutions
Today’s world is a challenging one and we are seeing so many changes within the development of new complex drugs such as biologics; the production and manufacturing process is proving more intricate and nuanced than ever before, drugs are in shorter supply, the shelf life details are unknown and there is limited understanding about specific drug’s performance and stability. This combined with the pressures clinical teams face to progress trials faster into later phases for commercialisation whilst meeting critical milestones on time and budget, these teams rely on robust clinical supply chain management experts from global CDMO businesses whose experience demonstrates their ability is to get it right and successfully bring clinical trials through to commercialisation, improving the lives of patients globally.
Almac’s core services and solutions are designed with flexibility to fit these unique clinical study requirements and challenges:
- Commercial Drug Procurement
- Clinical Supply Chain Management
- Blinding of Clinical Trial Supplies
- Analytical Services
- Clinical Trial Packaging Solutions
- Global Clinical Storage & Distribution
- Next Gen Temperature Management
- Qualified Person Services (QP)
From small Phase I studies, through to mega Phase III trials – Almac provides a range of options for clinical trial packaging and distribution needs.
About Clinical Trials Innovation Programme 2022
Clinical Trials Innovation Programme is an invitation-only, premium event bringing together a mix of clinical research professionals and service providers in one stimulating environment.
Join us face to face to learn from the best in the drug development industry and have an opportunity to learn from their experiences. With an agenda covering the future of Clinical trials and drug development post COVID, Clinical Trials Innovation Programme 2022 will feature tailored sessions presented by the leading experts from across the globe.
We are bringing together the best in the industry to help you learn and grow, and accelerate your drug development journey. The experts will include thought leaders and visionaries from Danish Medicines Agency, Bayer Pharmaceuticals, AstraZeneca The Janssen Pharmaceutical Companies of Johnson & Johnson, Travere Therapeutics, Biogen, Vifor Pharma, Medical Products Agency and much more.
Register with us to learn more!
About Pharma and Device Packaging and Labelling Forum 2022
Packaging innovation has had to accelerate at a faster rate than ever before in recent years to optimize drug delivery for pharma, healthcare professionals, and patients alike – but it's necessary to keep up with medical advances, stay ahead of competition, and accommodate the unique and differentiated needs of combination products, biologics, vaccines, and other specialty medicines.
We are inviting you to be a part of WORLD BI’s Pharma & Device Packaging and Labelling Forum 2022 to meet with the industry experts and visionaries from around the world to deliberate over the latest innovations & explore the growing opportunities in the Pharma packaging Industry.
The forum will deliver senior-level executive insights, unrivalled networking and knowledge sharing opportunities with high-value actionable content on multiple facets of the industry. Speakers from notable pharma and medical device companies like Medtronic, Aurobindo Pharma, Novartis, ESKO, Boehringer Ingelheim, Gradient, Metsä Board and many more will be joining and sharing their valuable insights.